Laquinimod, a Prototypic Quinoline-3-Carboxamide and Aryl Hydrocarbon Receptor Agonist, Utilizes a CD155-mediated Natural Killer/Dendritic Cell Interaction to Suppress CNS Autoimmunity
Journal of Neuroinflammation - United Kingdom
doi 10.1186/s12974-019-1437-0
Full Text
Open PDFAbstract
Available in full text
Date
February 26, 2019
Authors
Publisher
Springer Science and Business Media LLC